Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2645) 2645
Book Chapter (15) 15
Magazine Article (12) 12
Dissertation (5) 5
Book / eBook (2) 2
Book Review (2) 2
Newsletter (2) 2
Newspaper Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2202) 2202
science & technology (1980) 1980
life sciences & biomedicine (1936) 1936
sertraline - therapeutic use (1498) 1498
female (1453) 1453
male (1422) 1422
sertraline (1415) 1415
psychiatry (1201) 1201
adult (1117) 1117
serotonin uptake inhibitors - therapeutic use (1085) 1085
middle aged (877) 877
biological and medical sciences (853) 853
medical sciences (843) 843
antidepressive agents - therapeutic use (809) 809
treatment outcome (748) 748
pharmacology. drug treatments (648) 648
psychology. psychoanalysis. psychiatry (619) 619
pharmacology & pharmacy (610) 610
psychopharmacology (531) 531
neuropharmacology (527) 527
antidepressants (517) 517
aged (502) 502
neurosciences & neurology (458) 458
depressive disorder - drug therapy (453) 453
depression (452) 452
double-blind method (433) 433
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (413) 413
sertraline - adverse effects (402) 402
depressive disorder, major - drug therapy (401) 401
adolescent (395) 395
serotonin uptake inhibitors - adverse effects (354) 354
psychology (329) 329
1-naphthylamine - analogs & derivatives (327) 327
social sciences (327) 327
drug therapy (318) 318
clinical neurology (317) 317
neurosciences (312) 312
psychiatric status rating scales (306) 306
psychopathology. psychiatry (299) 299
1-naphthylamine - therapeutic use (290) 290
mental depression (261) 261
abridged index medicus (259) 259
fluoxetine - therapeutic use (248) 248
depression - drug therapy (245) 245
adult and adolescent clinical studies (237) 237
depression, mental (235) 235
sertraline - pharmacology (228) 228
fluoxetine (218) 218
paroxetine - therapeutic use (211) 211
animals (209) 209
antidepressive agents - adverse effects (204) 204
paroxetine (204) 204
sertraline - administration & dosage (204) 204
child (201) 201
psychology, clinical (197) 197
serotonin uptake inhibitors (196) 196
clinical trials (191) 191
dose-response relationship, drug (191) 191
care and treatment (189) 189
mood disorders (184) 184
depressive disorder - psychology (183) 183
serotonin (183) 183
serotonin uptake inhibitors - pharmacology (181) 181
drug therapy, combination (175) 175
severity of illness index (173) 173
research (170) 170
young adult (167) 167
citalopram (165) 165
combined modality therapy (159) 159
comorbidity (157) 157
analysis (156) 156
serotonin uptake inhibitors - administration & dosage (156) 156
citalopram - therapeutic use (153) 153
general & internal medicine (143) 143
medicine, general & internal (138) 138
obsessive-compulsive disorder - drug therapy (137) 137
ssris (136) 136
time factors (133) 133
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer (132) 132
follow-up studies (131) 131
medicine & public health (131) 131
drug administration schedule (130) 130
major depressive disorder (127) 127
placebos (125) 125
depressive disorder, major - psychology (123) 123
anxiety (119) 119
drug interactions (119) 119
health aspects (119) 119
ptsd (118) 118
pediatrics (117) 117
neurology (115) 115
cognitive therapy (111) 111
drugs (111) 111
quality of life (111) 111
randomized controlled trials as topic (110) 110
aged, 80 and over (109) 109
antidepressive agents - pharmacology (109) 109
depressive disorder, major - diagnosis (109) 109
antidepressive agents, second-generation - therapeutic use (106) 106
pharmacotherapy (103) 103
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2624) 2624
Russian (19) 19
Spanish (19) 19
German (17) 17
Portuguese (15) 15
French (12) 12
Chinese (9) 9
Turkish (6) 6
Danish (3) 3
Dutch (3) 3
Polish (3) 3
Hungarian (2) 2
Japanese (2) 2
Norwegian (2) 2
Croatian (1) 1
Hebrew (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials
by Hayasaka, Yu and Purgato, Marianna and Magni, Laura R and Ogawa, Yusuke and Takeshima, Nozomi and Cipriani, Andrea and Barbui, Corrado and Leucht, Stefan and Furukawa, Toshi A
Journal of affective disorders, ISSN 0165-0327, 2015, Volume 180, pp. 179 - 184
Psychiatry | Dose equivalence | Major depression | Fluoxetine | Antidepressive agents | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Fluvoxamine - therapeutic use | Double-Blind Method | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Male | Treatment Outcome | Paroxetine - therapeutic use | Evidence-Based Medicine | Moclobemide - therapeutic use | Randomized Controlled Trials as Topic | Antidepressive Agents - therapeutic use | Dose-Response Relationship, Drug | Nortriptyline - therapeutic use | Sertraline - therapeutic use | Adult | Citalopram - therapeutic use | Female | Amitriptyline - therapeutic use | Fluoxetine - therapeutic use | Bupropion - therapeutic use | Depressive Disorder, Major - drug therapy | Antidepressants, Tricyclic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pharmacotherapy of Pervasive Developmental Disorders in Children and Adolescents
by Gabriele Masi
2004, Volume 18, Issue 14, 22
Citalopram, therapeutic use | Clozapine, therapeutic use | Venlafaxine, therapeutic use | Amantadine, therapeutic use | Buspirone, therapeutic use | Ziprasidone, therapeutic use | Fluoxetine, therapeutic use | Pyridoxine, therapeutic use | Antipsychotics, therapeutic use | Valproate semisodium, therapeutic use | Naltrexone, therapeutic use | Niaprazine, therapeutic use | Clonidine, therapeutic use | Antidepressants, therapeutic use | Secretin, therapeutic use | Olanzapine, therapeutic use | Quetiapine, therapeutic use | Sertraline, therapeutic use | Lithium, therapeutic use | Paroxetine, therapeutic use | Mirtazapine, therapeutic use | Clomipramine, therapeutic use | Pervasive developmental disorders, treatment | Guanfacine, therapeutic use | Methylphenidate, therapeutic use | Fluvoxamine, therapeutic use | Risperidone, therapeutic use | Lamotrigine, therapeutic use | Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Other psychotic disorders | Psychology. Psychoanalysis. Psychiatry | Psychoses | Adult and adolescent clinical studies | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychotropic Drugs - adverse effects | Developmental Disabilities - drug therapy | Antipsychotic Agents - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Adolescent | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Clinical Trials as Topic | Child | Developmental Disabilities - psychology | Psychotropic Drugs - therapeutic use | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Current Concepts in the Pharmacotherapy of Paraphilias
by Garcia, Frederico D and Thibaut, Florence
Drugs (New York, N.Y.), ISSN 0012-6667, 4/2011, Volume 71, Issue 6, pp. 771 - 790
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Medroxyprogesterone, therapeutic use | Escitalopram, therapeutic use | Paraphilias, diagnosis | Paroxetine,therapeutic use | Sertraline, therapeutic use | Cyproterone, therapeutic use | Fluoxetine, therapeutic use | Leuprorelin, therapeutic use | Clomipramine, therapeutic use | Nefazodone, therapeutic use | Gonadotropin-releasing-hormone-stimulants, therapeutic use | Imipramine, therapeutic use | Fluvoxamine, therapeutic use | Triptorelin, therapeutic use | Serotonin-uptake-inhibitors, therapeutic use | Paraphilias, epidemiology | Paraphilias, treatment | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Sexual behavior disorders. Psychogenic sexual dysfunctions | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Humans | Gonadotropin-Releasing Hormone - administration & dosage | Gonadotropin-Releasing Hormone - adverse effects | Male | Treatment Outcome | Combined Modality Therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Paraphilic Disorders - drug therapy | Antidepressive Agents - therapeutic use | Psychotherapy - methods | Androgen Antagonists - therapeutic use | Antidepressive Agents - administration & dosage | Paraphilic Disorders - psychology | Gonadotropin-Releasing Hormone - therapeutic use | Androgen Antagonists - administration & dosage | Antidepressive Agents - adverse effects | Androgen Antagonists - adverse effects | Paraphilic Disorders - epidemiology | Sexual deviation | Care and treatment | Hormone therapy | Research | Diagnosis | Social aspects | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic Target
by Pettinati, Helen M and O’Brien, Charles P and Dundon, William D
The American journal of psychiatry, ISSN 0002-953X, 1/2013, Volume 170, Issue 1, pp. 23 - 30
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Desintoxication. Drug withdrawal | Medical sciences | Neuropharmacology | Treatments | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Naltrexone - therapeutic use | Substance-Related Disorders - rehabilitation | Mood Disorders - psychology | Antipsychotic Agents - adverse effects | Humans | Sertraline - adverse effects | Alcoholism - diagnosis | Bipolar Disorder - diagnosis | Depressive Disorder, Major - epidemiology | Psychotropic Drugs - therapeutic use | Mood Disorders - epidemiology | Psychotropic Drugs - adverse effects | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Mood Disorders - rehabilitation | Sertraline - therapeutic use | Drug Therapy, Combination | Alcoholism - psychology | Antimanic Agents - adverse effects | Substance-Related Disorders - diagnosis | Bipolar Disorder - rehabilitation | Antimanic Agents - therapeutic use | Double-Blind Method | Comorbidity | Narcotic Antagonists - adverse effects | Depressive Disorder, Major - rehabilitation | Combined Modality Therapy | Controlled Clinical Trials as Topic | Alcoholism - epidemiology | Alcoholism - rehabilitation | Bipolar Disorder - psychology | Antidepressive Agents - therapeutic use | Depressive Disorder, Major - psychology | Narcotic Antagonists - therapeutic use | Mood Disorders - diagnosis | Substance-Related Disorders - psychology | Cognitive Therapy | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Naltrexone - adverse effects | Bipolar Disorder - epidemiology | Diagnosis, Dual (Psychiatry) | Psychological aspects | Drug abuse | Care and treatment | Physiological aspects | Mood (Psychology) | Psychotherapy | Health aspects | Methods | Bipolar disorder | Mental depression | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Awakenings and awareness recovery in disorders of consciousness: Is there a role for drugs?
by Pistoia, Francesca and Mura, Elisa and Govoni, Stefano and Fini, Massimo and Sarà, Marco
CNS drugs, ISSN 1172-7047, 2010, Volume 24, Issue 8, pp. 625 - 638
Coma | Consciousness-disorders | Amantadine, therapeutic use | Protriptyline, therapeutic use | Sertraline, therapeutic use | Baclofen, therapeutic use | Amitriptyline, therapeutic use | Amfetamine, therapeutic use | Pramipexole, therapeutic use | Zolpidem, therapeutic use | Apomorphine, therapeutic use | Levodopa, therapeutic use | Desipramine, therapeutic use | Methylphenidate, therapeutic use | Lamotrigine, therapeutic use | Consciousness - drug effects | MEDLINE | Central Nervous System Stimulants - pharmacology | Humans | Cognition - drug effects | Persistent Vegetative State - drug therapy | Central Nervous System Depressants - pharmacology | Central Nervous System Stimulants - therapeutic use | Central Nervous System Depressants - therapeutic use | Central Nervous System Stimulants - metabolism | Coma - drug therapy | Consciousness Disorders - drug therapy | Central Nervous System Depressants - metabolism
Journal Article
Details down arrow
6. Full Text Obsessive-Compulsive Disorder in Schizophrenia: Clinical Characteristics and Treatment
by Michael Poyurovsky and Abraham Weizman and Ronit Weizman
CNS drugs, ISSN 1172-7047, 2004, Volume 18, Issue 14, pp. 989 - 1010
Clozapine, therapeutic use | Olanzapine, therapeutic use | Quetiapine, therapeutic use | Schizophrenia, treatment | Sertraline, therapeutic use | Serotonin reuptake inhibitors, therapeutic use | Fluoxetine, therapeutic use | Paroxetine, therapeutic use | Antipsychotics, therapeutic use | Clomipramine, therapeutic use | Chlorpromazine, therapeutic use | Obsessive compulsive disorders, treatment | Antidepressants, therapeutic use | Fluvoxamine, therapeutic use | Clotiapine, therapeutic use | Risperidone, therapeutic use | Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Anxiety disorders. Neuroses | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Obsessive-compulsive disorders | Obsessive-Compulsive Disorder - epidemiology | Antipsychotic Agents - adverse effects | Humans | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Schizophrenia - complications | Clinical Trials as Topic | Schizophrenia - epidemiology | Obsessive-Compulsive Disorder - complications | Obsessive-Compulsive Disorder - drug therapy | Antipsychotic Agents - therapeutic use | Obsessive-Compulsive Disorder - chemically induced | Schizophrenia - drug therapy | Practice Guidelines as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study
by Popova, Vanina and Daly, Ella J and Trivedi, Madhukar and Cooper, Kimberly and Lane, Rosanne and Lim, Pilar and Mazzucco, Christine and Hough, David and Thase, Michael E and Shelton, Richard C and Molero, Patricio and Vieta, Eduard and Bajbouj, Malek and Manji, Husseini and Drevets, Wayne C and Singh, Jaskaran B
The American journal of psychiatry, ISSN 0002-953X, 06/2019, Volume 176, Issue 6, pp. 428 - 438
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Double-Blind Method | Duloxetine Hydrochloride - therapeutic use | Administration, Oral | Humans | Middle Aged | Male | Treatment Outcome | Venlafaxine Hydrochloride - therapeutic use | Depressive Disorder, Treatment-Resistant - drug therapy | Administration, Intranasal | Antidepressive Agents - therapeutic use | Sertraline - therapeutic use | Adult | Citalopram - therapeutic use | Female | Ketamine - therapeutic use | Drug Therapy, Combination | Depressive Disorder, Major - drug therapy | Mental depression | Antidepressants | Medical treatment | Drug administration | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights